{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T08:43:07Z","timestamp":1767861787526,"version":"3.49.0"},"reference-count":32,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hepatic venoocclusive disease (HVOD) in bone marrow transplantation (BMT) is attributed to toxicity of cytoreductive agents, especially busulfan and cyclophosphamide, in the conditioning therapy. Busulfan, as well as the metabolites of cyclophosphamide, are conjugated with glutathione (GSH), catalyzed by enzymes of the glutathione S-transferase (GST) family. To assess the impact of polymorphisms of the GST genes, GSTM1 and GSTT1, on the risk of HVOD, we evaluated 114 consecutive patients with \u03b2-thalassemia major undergoing BMT. There was a significantly increased incidence of HVOD in patients with the GSTM1-null genotype compared with those with the GSTM1-positive genotype (46.5% vs 18.3%; P = .001). Pharmacokinetic analysis in these patients showed that the clearance of busulfan was higher and first-dose steady-state concentration was lower among those with HVOD (0.403 \u00b1 0.06 vs 0.33 \u00b1 0.071 L\/h\/kg, Student t test P value = .000 01; and 508 \u00b1 125 vs 656 \u00b1 255 ng\/mL, t test P value = .001, respectively). We conclude that the GSTM1-null genotype predisposes to HVOD, and the sinusoidal endothelial cells and hepatocyte damage may be mediated by metabolites of busulfan through depletion of the cellular GSH pool.<\/jats:p>","DOI":"10.1182\/blood-2003-11-3778","type":"journal-article","created":{"date-parts":[[2004,5,18]],"date-time":"2004-05-18T00:13:27Z","timestamp":1084839207000},"page":"1574-1577","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":147,"title":["Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation"],"prefix":"10.1182","volume":"104","author":[{"given":"Alok","family":"Srivastava","sequence":"first","affiliation":[{"name":"From the Department of Haematology, Christian Medical College, Vellore, India; and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U 458, Hopital Robert Debre, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balasubramanian","family":"Poonkuzhali","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Christian Medical College, Vellore, India; and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U 458, Hopital Robert Debre, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramachandran V.","family":"Shaji","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Christian Medical College, Vellore, India; and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U 458, Hopital Robert Debre, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biju","family":"George","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Christian Medical College, Vellore, India; and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U 458, Hopital Robert Debre, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Mathews","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Christian Medical College, Vellore, India; and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U 458, Hopital Robert Debre, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mammen","family":"Chandy","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Christian Medical College, Vellore, India; and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U 458, Hopital Robert Debre, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajagopal","family":"Krishnamoorthy","sequence":"additional","affiliation":[{"name":"From the Department of Haematology, Christian Medical College, Vellore, India; and Institut National de la Sante\u0301 et de la Recherche Me\u0301dicale (INSERM) U 458, Hopital Robert Debre, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021223194217100_REF1","doi-asserted-by":"crossref","unstructured":"Wadleigh M, Ho V, Momtaz P, Rishardson P. Hepatic veno-occlusive disease- pathogenesis, diagnosis and treatment. Curr Opin Hematol.2003;10: 451-462.","DOI":"10.1097\/00062752-200311000-00010"},{"key":"2020021223194217100_REF2","doi-asserted-by":"crossref","unstructured":"DeLeve LD, Shulman HM, McDonald GB. Toxic injury to the hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis.2002;22: 27-42.","DOI":"10.1055\/s-2002-23204"},{"key":"2020021223194217100_REF3","doi-asserted-by":"crossref","unstructured":"Bearman SI. Avoiding hepatic veno-occlusive disease: what do we know and where are we going? Bone Marrow Transplant.2001;27: 1113-1120.","DOI":"10.1038\/sj.bmt.1703014"},{"key":"2020021223194217100_REF4","doi-asserted-by":"crossref","unstructured":"Barker CC, Butzner JD, Anderson RA, Brant R, Sauve RS. Incidence, survival and risk factors for the development of veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients. Bone Marrow Transplant.2003;32: 79-87.","DOI":"10.1038\/sj.bmt.1704069"},{"key":"2020021223194217100_REF5","doi-asserted-by":"crossref","unstructured":"Carreras E. Veno-occlusive disease of the liver after hemopoietic cell transplantation. Eur J Haematol.2000;64: 281-291.","DOI":"10.1034\/j.1600-0609.2000.9r200.x"},{"key":"2020021223194217100_REF6","doi-asserted-by":"crossref","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute non-lymphocytic leukaemia after treatment with busulfan and cyclophosphamide. N Engl J Med.1983;309: 1347-1353.","DOI":"10.1056\/NEJM198312013092202"},{"key":"2020021223194217100_REF7","doi-asserted-by":"crossref","unstructured":"Clift RA, Buckner CD, Thomas ED, et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide. Blood. 1994;84: 2036-2043.","DOI":"10.1182\/blood.V84.6.2036.2036"},{"key":"2020021223194217100_REF8","doi-asserted-by":"crossref","unstructured":"DeLeve LD. Hepatic venoocclusive disease: a major complication of hematopoietic stem cell transplantation in cancer patients. Tumori. 2001;87: S28-S30.","DOI":"10.1177\/030089160108700224"},{"key":"2020021223194217100_REF9","unstructured":"Slattery JT, Sanders JE, Buckner CD, et al. Graft rejection and toxicity in relation to busulfan pharmacokinetics. Bone Marrow Transplant.1995;16: 31-42."},{"key":"2020021223194217100_REF10","doi-asserted-by":"crossref","unstructured":"McDonald GB, Slattery JT, Bouvier ME, et al. Cyclophosphamide metabolism, liver toxicity and mortality following hematopoietic stem cell transplantation. Blood. 2003;101: 2043-2048.","DOI":"10.1182\/blood-2002-06-1860"},{"key":"2020021223194217100_REF11","doi-asserted-by":"crossref","unstructured":"Hassan M, Ljungman P, Ringden O, et al. Effect of busulfan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy related toxicity. Bone Marrow Transplant.2000;25: 915-924.","DOI":"10.1038\/sj.bmt.1702377"},{"key":"2020021223194217100_REF12","doi-asserted-by":"crossref","unstructured":"Dirven HA, Van Ommen B, Van Bladeren PJ, et al. Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases. Chem Res Toxicol.1996;9: 351-360.","DOI":"10.1021\/tx950143c"},{"key":"2020021223194217100_REF13","unstructured":"Czerwinski M, Gibbs JP, Slattery JT. Busulfan conjugation by glutathione S-transferases \u03b1, \u03bc, and \u03c0. Drug Metabol Disp.1996;24: 1015-1019."},{"key":"2020021223194217100_REF14","unstructured":"Gibbs JP, Czerwinski M, Slattery JT. Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione S-transferases. Cancer Res.1996;56: 3678-3681."},{"key":"2020021223194217100_REF15","doi-asserted-by":"crossref","unstructured":"Nelson HH, Wiencke JK, Christiani DC, et al. Ethnic difference in the prevalence of the homozygous deleted genotype of GST. Carcinogenesis. 1995;16: 1243-1245.","DOI":"10.1093\/carcin\/16.5.1243"},{"key":"2020021223194217100_REF16","doi-asserted-by":"crossref","unstructured":"Arruda VR, Grignolli CE, Gonclaves MS, et al. Prevalence of homozygosity for the deleted alleles of GSTM1 and GSTT1 among distinct ethnic groups from Brazil: relevance to environmental carcinogenesis? Clin Genet.1998;54: 210-214.","DOI":"10.1111\/j.1399-0004.1998.tb04286.x"},{"key":"2020021223194217100_REF17","doi-asserted-by":"crossref","unstructured":"DeLeve D, Wang X. Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes. Pharmacology. 2000;60: 143-154.","DOI":"10.1159\/000028359"},{"key":"2020021223194217100_REF18","doi-asserted-by":"crossref","unstructured":"Poonkuzhali B, Srivastava A, Quernin MH, et al. Pharmacokinetics of oral busulphan in children with beta thalassemia major undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant.1999;24: 5-11.","DOI":"10.1038\/sj.bmt.1701814"},{"key":"2020021223194217100_REF19","doi-asserted-by":"crossref","unstructured":"Li CK, Yuen PM, Wong R, et al. Busulphan level and early mortality in thalassaemia patients after BMT. Bone Marrow Transplant.1999;23: 307-310.","DOI":"10.1038\/sj.bmt.1701584"},{"key":"2020021223194217100_REF20","doi-asserted-by":"crossref","unstructured":"Jones RJ, Lee KSK, Beschorner WE, et al. Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation. 1987;44: 778-783.","DOI":"10.1097\/00007890-198712000-00011"},{"key":"2020021223194217100_REF21","doi-asserted-by":"crossref","unstructured":"Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia. New Engl J Med.1990;332: 417-421.","DOI":"10.1056\/NEJM199002153220701"},{"key":"2020021223194217100_REF22","doi-asserted-by":"crossref","unstructured":"Quernin MH, Poonkuzhali B, Medard Y, et al. High-performance liquid chromatographic method for quantification of busulfan in plasma after derivatization by tetrafluorothiophenol. J Chromatogr.1999;721: 147-152.","DOI":"10.1016\/S0378-4347(98)00473-3"},{"key":"2020021223194217100_REF23","unstructured":"Heinzel G, Woloszezak R, Thoman P. Pharmacokinetic pharmacodynamic data analysis system for the PC. Stuttgart, Germany: Gustav Fischer; 1993."},{"key":"2020021223194217100_REF24","doi-asserted-by":"crossref","unstructured":"Pfeiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay for total plasma homocysteine and cysteine in a clinical laboratory setting. Clin Chem.1999;45: 290-292.","DOI":"10.1093\/clinchem\/45.2.290"},{"key":"2020021223194217100_REF25","doi-asserted-by":"crossref","unstructured":"Arand M, Mullbauer R, Hengstler J, et al. A multiplex polymerase chain reaction protocol for the simultaneous analysis of the GSTM1 and GSTT1 polymorphisms. Anal Biochem.1996;236: 184-186.","DOI":"10.1006\/abio.1996.0153"},{"key":"2020021223194217100_REF26","unstructured":"Dean AG, Dean JA, Coulombier D, et al. Epi Info version 6: a word processing database and statistical program for epidemiology on microcomputers. Atlanta, GA: Centers for Disease Control and Prevention; 1994."},{"key":"2020021223194217100_REF27","doi-asserted-by":"crossref","unstructured":"Slattery JT, Kalhorn TF, McDonald GB, et al. Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients. J Clin Oncol.1996;14: 1484-1494.","DOI":"10.1200\/JCO.1996.14.5.1484"},{"key":"2020021223194217100_REF28","doi-asserted-by":"crossref","unstructured":"DeLeve LD, Wang X, Kuhlenkamp JF, Kaplowitz N. Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic veno-occlusive disease. Hepatology. 1996;23: 589-599.","DOI":"10.1002\/hep.510230326"},{"key":"2020021223194217100_REF29","unstructured":"Poonkuzhali B, Lapoumeroulie C, Shaji RV, et al. GSTM1 null genotype is associated with elevated GST \u03b1 expression in children with beta thalassemia major [abstract]. Blood. 2002;100: 4373b. Abstract 4373."},{"key":"2020021223194217100_REF30","doi-asserted-by":"crossref","unstructured":"Ritter CA, Sperker B, Grube M, et al. Overexpression of glutathione S-transferase A1\u20131 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression. Br J Pharmacol.2002;137: 1100-1106.","DOI":"10.1038\/sj.bjp.0704972"},{"key":"2020021223194217100_REF31","doi-asserted-by":"crossref","unstructured":"Sreelekha TT, Ramadas K, Pandey M, Thomas G, Nalinakumari KR, Pillai MR. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol.2001;37: 593-598.","DOI":"10.1016\/S1368-8375(01)00028-8"},{"key":"2020021223194217100_REF32","unstructured":"Garte S, Gaspari L, Alexandrie A-K, et al. Metabolic gene polymorphisms in control populations. Cancer Epidemiol Biomarkers Prev.2001;10: 1239-1248."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/5\/1574\/1701261\/zh801704001574.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/104\/5\/1574\/1701261\/zh801704001574.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T04:19:56Z","timestamp":1581567596000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/104\/5\/1574\/18919\/Glutathione-Stransferase-M1-polymorphism-a-risk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,1]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-11-3778","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,1]]}}}